Daewoong Co., Ltd. (KRX:003090)
27,550
-450 (-1.61%)
At close: Jun 5, 2025, 3:30 PM KST
Daewoong Revenue
Daewoong had revenue of 481.43B KRW in the quarter ending March 31, 2025, with 8.47% growth. This brings the company's revenue in the last twelve months to 1.97T, up 8.38% year-over-year. In the year 2024, Daewoong had annual revenue of 1.94T with 6.79% growth.
Revenue (ttm)
1,974.49B
Revenue Growth
+8.38%
P/S Ratio
0.57
Revenue / Employee
5.55B
Employees
356
Market Cap
1,126.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,936.92B | 123.08B | 6.79% |
Dec 31, 2023 | 1,813.84B | 116.50B | 6.86% |
Dec 31, 2022 | 1,697.34B | 185.96B | 12.30% |
Dec 31, 2021 | 1,511.37B | 156.04B | 11.51% |
Dec 31, 2020 | 1,355.34B | -10.34B | -0.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |